The key equity benchmarks further pared losses and traded with minor cuts in early afternoon trade. The Nifty traded above the 17,750 level.
At 12:40 IST, the S&P BSE Sensex fell 125.12 points or 0.21% at 59,485.29. The Nifty 50 index shed 32.80 points or 0.18% at 17,774.85.
The broader market traded with gains. The S&P BSE Mid-Cap index rose 0.64% while the S&P BSE Small-Cap index gained 0.59%.
The market breadth, indicating the overall health of the market, was positive. On the BSE, 2173 shares rose and 1128 shares fell. A total of 123 shares were unchanged.
Economy:
Asian Development Bank (ADB) on Wednesday said that South Asian economies are expected to expand collectively by 7.0% in 2022 and 7.4% in 2023, with Indiathe subregion's largest economyexpected to grow 7.5% this fiscal year and 8.0% next fiscal year.
ADB said developing Asia's economies are forecast to grow 5.2% this year and 5.3% in 2023, thanks to a robust recovery in domestic demand and continued expansion in exports. "However, uncertainties stemming from the Russian invasion of Ukraine, the continuing coronavirus disease (COVID-19) pandemic, and tightening by the United States Federal Reserve pose risks to the outlook," ADB Outlook said.
Stocks in Spotlight:
BLS International Services surged 17.32% to Rs 330.55 after the company said that its board will meet on 13 April 2022 to consider the proposal for issue of bonus shares to its equity shareholders.
Man Industries (India) gained 1.51% to Rs 101 after the company said that it has entered into a technical collaboration and know-how agreement with Singapore-based OMS Oilfield Services.
Alembic Pharmaceuticals advanced 2.56% to Rs 780 on securing a tentative approval from the United States Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) of Dabigatran Etexilate capsules, 75 mg, 110 mg, and 150 mg.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU